title: Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.
abstract: Anti-GD1a ganglioside antibodies (Abs) are the serological hallmark of the acute motor axonal form of the post-infectious paralysis, Guillain-Barre syndrome. Development of a disease model in mice has been impeded by the weak immunogenicity of gangliosides and the apparent resistance of GD1a-containing neural membranes to anti-GD1a antibody-mediated injury. Here we used mice with altered ganglioside biosynthesis to generate such a model at motor nerve terminals. First, we bypassed immunological tolerance by immunizing GD1a-deficient, beta-1,4-N-acetylgalactosaminyl transferase knock-out mice with GD1a ganglioside-mimicking antigens from Campylobacter jejuni and generated high-titer anti-GD1a antisera and complement fixing monoclonal Abs (mAbs). Next, we exposed ex vivo nerve-muscle preparations from GD1a-overexpressing, GD3 synthase knock-out mice to the anti-GD1a mAbs in the presence of a source of complement and investigated morphological and electrophysiological damage. Dense antibody and complement deposits were observed only over presynaptic motor axons, accompanied by severe ultrastructural damage and electrophysiological blockade of motor nerve terminal function. Perisynaptic Schwann cells and postsynaptic membranes were unaffected. In contrast, normal mice were not only unresponsive to immunization with GD1a but also resistant to neural injury during anti-GD1a Ab exposure, demonstrating the central role of membrane antigen density in modulating both immune tolerance to GD1a and axonal susceptibility to anti-GD1a Abmediated injury. Identical paralyzing effects were observed when testing mouse and human anti-GD1a-positive sera. These data indicate that anti-GD1a Abs arise via molecular mimicry and are likely to be clinically relevant in injuring peripheral nerve axonal membranes containing sufficiently high levels of GD1a.
authors.affiliation: Division of Clinical Neurosciences, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, United Kingdom.
authors.forename: John A
authors.initials: JA
authors.lastname: Goodfellow
authors.forename: Tyrone
authors.initials: T
authors.lastname: Bowes
authors.forename: Kazim
authors.initials: K
authors.lastname: Sheikh
authors.forename: Masaaki
authors.initials: M
authors.lastname: Odaka
authors.forename: Susan K
authors.initials: SK
authors.lastname: Halstead
authors.forename: Peter D
authors.initials: PD
authors.lastname: Humphreys
authors.forename: Eric R
authors.initials: ER
authors.lastname: Wagner
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Yuki
authors.forename: Koichi
authors.initials: K
authors.lastname: Furukawa
authors.forename: Keiko
authors.initials: K
authors.lastname: Furukawa
authors.forename: Jaap J
authors.initials: JJ
authors.lastname: Plomp
authors.forename: Hugh J
authors.initials: HJ
authors.lastname: Willison
mesh_terms: D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology*; D001324:Autoantigens / Q000096:biosynthesis / Q000276:immunology*; D001369:Axons / Q000276:immunology; D016123:Campylobacter jejuni / Q000276:immunology; D003167:Complement Activation; D004195:Disease Models, Animal; D005732:Gangliosides / Q000096:biosynthesis / Q000276:immunology*; D020275:Guillain-Barre Syndrome / Q000209:etiology / Q000276:immunology; D007108:Immune Tolerance; D007114:Immunization; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D018345:Mice, Knockout; D018716:Molecular Mimicry / Q000276:immunology*; D009046:Motor Neurons / Q000276:immunology / Q000502:physiology*; D017350:N-Acetylgalactosaminyltransferases / Q000172:deficiency / Q000235:genetics; D020721:Nervous System Autoimmune Disease, Experimental / Q000209:etiology / Q000276:immunology*; D009469:Neuromuscular Junction / Q000276:immunology* / Q000503:physiopathology / Q000648:ultrastructure; D012799:Sialyltransferases / Q000172:deficiency / Q000235:genetics; D000097763:Polypeptide N-acetylgalactosaminyltransferase
chemical_list: D000942:Antigens, Bacterial; D001323:Autoantibodies; D001324:Autoantigens; D005732:Gangliosides; D017350:N-Acetylgalactosaminyltransferases; D012799:Sialyltransferases; D000097763:Polypeptide N-acetylgalactosaminyltransferase; C021298:ganglioside, GD1a; C043662:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase
references.citation: Muscle Nerve. 1999 May;22(5):640-4
references.pmid: 10331365
references.citation: J Clin Invest. 1999 Sep;104(6):697-708
references.pmid: 10491405
references.citation: J Neuroimmunol. 1999 Dec;100(1-2):74-97
references.pmid: 10695718
references.citation: Physiol Rev. 2000 Apr;80(2):717-66
references.pmid: 10747206
references.citation: Neurology. 2000 Apr 11;54(7):1453-8
references.pmid: 10751257
references.citation: J Neurochem. 2000 Jul;75(1):404-12
references.pmid: 10854286
references.citation: Muscle Nerve. 2000 Jul;23(7):1035-43
references.pmid: 10882997
references.citation: Ann Neurol. 2000 Oct;48(4):624-31
references.pmid: 11026446
references.citation: J Biol Chem. 2001 Mar 9;276(10):6885-8
references.pmid: 11133999
references.citation: Brain. 2001 May;124(Pt 5):893-906
references.pmid: 11335692
references.citation: Res Commun Mol Pathol Pharmacol. 2001 Jul;109(1-2):115-23
references.pmid: 11458979
references.citation: J Biol Chem. 2002 Jan 18;277(3):1633-6
references.pmid: 11682464
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13306-11
references.pmid: 11687633
references.citation: J Neuroimmunol. 2001 Dec 3;121(1-2):79-82
references.pmid: 11730943
references.citation: Am J Physiol Cell Physiol. 2002 Jan;282(1):C213-8
references.pmid: 11742814
references.citation: Neuromuscul Disord. 2002 Mar;12(3):292-3
references.pmid: 11801402
references.citation: Anal Biochem. 2002 Mar 15;302(2):276-84
references.pmid: 11878808
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8412-7
references.pmid: 12060784
references.citation: J Neurosci. 2002 Aug 15;22(16):6876-84
references.pmid: 12177185
references.citation: Infect Immun. 2002 Sep;70(9):5008-18
references.pmid: 12183547
references.citation: Brain. 2002 Nov;125(Pt 11):2491-506
references.pmid: 12390975
references.citation: Brain. 2002 Dec;125(Pt 12):2591-625
references.pmid: 12429589
references.citation: Muscle Nerve. 2003 Apr;27(4):426-34
references.pmid: 12661043
references.citation: Brain. 2003 Nov;126(Pt 11):2497-509
references.pmid: 12937083
references.citation: J Neurochem. 1992 Nov;59(5):1844-9
references.pmid: 1402926
references.citation: Muscle Nerve. 2003 Dec;28(6):683-9
references.pmid: 14639581
references.citation: Brain. 2004 May;127(Pt 5):1085-100
references.pmid: 14985267
references.citation: J Neurocytol. 2003 Jun-Sep;32(5-8):915-29
references.pmid: 15034276
references.citation: Brain. 2004 Sep;127(Pt 9):2109-23
references.pmid: 15289269
references.citation: Ann Neurol. 2004 Aug;56(2):228-39
references.pmid: 15293275
references.citation: Proc Natl Acad Sci U S A. 1977 Sep;74(9):3782-6
references.pmid: 269432
references.citation: J Neurol Sci. 1986 Jul;74(2-3):279-87
references.pmid: 3016202
references.citation: J Supramol Struct. 1978;8(1):1-17
references.pmid: 366282
references.citation: J Clin Invest. 1987 Nov;80(5):1492-7
references.pmid: 3680509
references.citation: Brain. 1986 Dec;109 ( Pt 6):1115-26
references.pmid: 3790970
references.citation: Eur J Biochem. 1995 Aug 1;231(3):570-8
references.pmid: 7544281
references.citation: J Immunol. 1995 Sep 15;155(6):3049-59
references.pmid: 7673721
references.citation: Prog Brain Res. 1994;101:XI-XIV
references.pmid: 8029441
references.citation: Infect Immun. 1994 May;62(5):2122-5
references.pmid: 8168981
references.citation: Cancer Res. 1994 Jan 1;54(1):197-203
references.pmid: 8261439
references.citation: J Neurocytol. 1996 Jan;25(1):33-51
references.pmid: 8852937
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10662-7
references.pmid: 8855236
references.citation: Ann Neurol. 1996 Oct;40(4):635-44
references.pmid: 8871584
references.citation: Mol Med. 1996 Nov;2(6):755-65
references.pmid: 8972490
references.citation: Brain Res. 1997 Jan 16;745(1-2):32-6
references.pmid: 9037391
references.citation: Neurology. 1997 Mar;48(3):717-24
references.pmid: 9065554
references.citation: J Neurol Sci. 1997 Apr 15;147(2):193-200
references.pmid: 9106127
references.citation: Nature. 1997 Jun 5;387(6633):569-72
references.pmid: 9177342
references.citation: J Infect Dis. 1997 Dec;176 Suppl 2:S92-8
references.pmid: 9396689
references.citation: Ann N Y Acad Sci. 1998 Jun 19;845:307-21
references.pmid: 9668364
references.citation: Ann Neurol. 1999 Feb;45(2):168-73
references.pmid: 9989618
references.citation: Ann Neurol. 1999 Feb;45(2):189-99
references.pmid: 9989621